Loading…
Nexalin Technology, Inc. is projected to rise to $0.4712 by 2027, a +29% move from its current price of $0.3649. NXL is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.3406 | $0.3649 | $0.391 | +0.01% |
| Aug 6 | $0.331 | $0.365 | $0.4024 | +0.02% |
| Aug 7 | $0.3239 | $0.365 | $0.4114 | +0.04% |
| Aug 8 | $0.318 | $0.3651 | $0.4191 | +0.05% |
| Aug 9 | $0.3129 | $0.3651 | $0.4261 | +0.06% |
| Aug 10 | $0.3084 | $0.3652 | $0.4324 | +0.07% |
| Aug 11 | $0.3042 | $0.3652 | $0.4384 | +0.08% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.3042 | $0.3652 | $0.4384 | +0.08% |
| Week 2 | $0.2823 | $0.3655 | $0.4733 | +0.17% |
| Week 3 | $0.2666 | $0.3658 | $0.502 | +0.25% |
| Week 4 | $0.2541 | $0.3661 | $0.5276 | +0.34% |
| Week 5 | $0.2436 | $0.3664 | $0.5513 | +0.42% |
| Week 6 | $0.2345 | $0.3668 | $0.5737 | +0.51% |
| Week 7 | $0.2264 | $0.3671 | $0.5951 | +0.59% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Nexalin Technology, Inc. is a healthcare company that designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China.
The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia.
Nexalin Technology, Inc. is headquartered in Houston, Texas.
Nexalin Technology, Inc. (NXL) is trading at $0.3611 and has a market cap of $7.95M, ranking 5157 by market cap.
The current price and market position place the stock among smaller-cap healthcare device names. The forecast trajectory shows a path of gradual price growth in the coming years, with notable upside later in the horizon: the 2026 avg price is $0.3611 with ROI 0% and a Neutral sentiment, followed by rising averages and positive ROIs in subsequent years.
By 2040 the forecasted average price is $1.17 with ROI 223.5%, and by 2050 the forecasted average price is $1.36 with ROI 276.6%, indicating meaningful long-term upside while recognizing the uncertainty inherent in future estimates.
A major floor 38.2% below — a decisive break under it would weaken the trend.
The nearest floor, 9.6% below — buyers have tended to step in here.
The nearest ceiling, 34.6% above — a clean break opens room to run.
A major ceiling 67.2% above — clearing it would confirm fresh momentum.
Key NXL support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NXL market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.3636 | Buy | $0.3665 | Sell |
| MA 10 | $0.4201 | Sell | $0.3941 | Sell |
| MA 20 | $0.4225 | Sell | $0.4087 | Sell |
| MA 50 | $0.4314 | Sell | $0.4172 | Sell |
| MA 100 | $0.4104 | Sell | $0.4596 | Sell |
| MA 200 | $0.6388 | Sell | $0.6288 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 39.22 | Neutral |
| Stoch RSI (14) | 6.85 | Buy |
| CCI (20) | -114.89 | Sell |
| Williams %R (14) | -98.08 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -27.93 | Sell |
| Bollinger %B (20,2) | 0.11 | Neutral |
| Stochastic %K (14) | 1.92 | Buy |
| TRIX (15) | 0.13 | Buy |
| Awesome (5,34) | -0.04 | Sell |
| Ultimate (7,14,28) | 30.78 | Neutral |
| Momentum (10) | -0.14 | Sell |
| Aroon Osc (25) | 52.00 | Buy |
| Hull MA (9) | 0.31 | Buy |
| ADX (14) | 16.86 | Neutral |
| ATR (14) | 0.03 | Info |
The 30-day technical picture is BEARISH.
RSI(14) is 40, indicating softer momentum near the short horizon. The moving averages show resistance from higher levels compared with the near-term price: the SMA50 is $0.4307 and the SMA200 is $0.6485.
Support is indicated at $0.33 and resistance at $0.491. The 30-day price range spans from a low of $0.2237 to a high of $0.583, underscoring recent volatility and tighter price action near current levels.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.321 | $0.3649 | $0.51 | 0% | Neutral | |
| $0.3434 | $0.4712 | $0.6988 | +29% | Bullish | |
| $0.3864 | $0.5639 | $0.8924 | +55% | Bullish | |
| $0.3279 | $0.5044 | $0.8386 | +38% | Bullish | |
| $0.2544 | $0.4102 | $0.7103 | +12% | Neutral | |
| $0.2921 | $0.4924 | $0.8828 | +35% | Bullish | |
| $0.2825 | $0.4969 | $0.9187 | +36% | Bullish | |
| $0.3399 | $0.6225 | $1.18 | +71% | Bullish | |
| $0.4089 | $0.7792 | $1.52 | +114% | Bullish | |
| $0.3476 | $0.6885 | $1.37 | +89% | Bullish | |
| $0.497 | $1.10 | $2.42 | +203% | Bullish | |
| $0.5754 | $1.28 | $2.94 | +250% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.321 | $0.3649 | $0.4491 | +0.00% |
| September 2026 | $0.2862 | $0.3479 | $0.4411 | -4.67% |
| October 2026 | $0.2993 | $0.3689 | $0.4774 | +6.06% |
| November 2026 | $0.3147 | $0.3923 | $0.5159 | +6.33% |
| December 2026 | $0.3034 | $0.3822 | $0.51 | -2.56% |
Click any year to see its month-by-month NXL forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect NXL to range from $0.321 to $0.51 through 2026. The $0.3649 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The NXL price prediction for 2027 points to an average of $0.4712 (low $0.3434, high $0.6988) — a potential gain of +29% on today's $0.3649. Momentum favours further upside here.
In 2028, NXL is projected to trade between $0.3864 and $0.8924, averaging $0.5639 — a potential gain of +55% from today's $0.3649. That is up +20% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Nexalin Technology, Inc.'s 2029 outlook centres on $0.5044, within a $0.3279 to $0.8386 range. That is -11% versus the projected 2028 average. That marks a +38% change versus current levels. Momentum favours further upside here.
By 2030, NXL could reach as high as $0.7103, with a base case around $0.4102 and support toward $0.2544 — roughly +12% from $0.3649. A consolidation phase looks the most probable path here.
Expect NXL to range from $0.2921 to $0.8828 through 2031. The $0.4924 average target implies a +35% move from current prices. That is up +20% on the projected 2030 average. Momentum favours further upside here.
The NXL price prediction for 2032 points to an average of $0.4969 (low $0.2825, high $0.9187) — a potential gain of +36% on today's $0.3649. Buyers look set to stay in control over this stretch.
In 2033, NXL is projected to trade between $0.3399 and $1.18, averaging $0.6225 — a potential gain of +71% from today's $0.3649. That is up +25% on the projected 2032 average. Momentum favours further upside here.
Nexalin Technology, Inc.'s 2034 outlook centres on $0.7792, within a $0.4089 to $1.52 range. That is up +25% on the projected 2033 average. That marks a +114% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, NXL could reach as high as $1.37, with a base case around $0.6885 and support toward $0.3476 — roughly +89% from $0.3649. Momentum favours further upside here.
Expect NXL to range from $0.497 to $2.42 through 2040. The $1.10 average target implies a +203% move from current prices. That is up +60% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The NXL price prediction for 2050 points to an average of $1.28 (low $0.5754, high $2.94) — a potential gain of +250% on today's $0.3649. Momentum favours further upside here.
Investing $1,000 in NXL today (≈ 2,740.476843 NXL) could be worth
$3,504.32
+$2,504.32 (+250%) by 2050 · US Dollar
Based on the average projected NXL price of $1.28 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NXLwould be worth at today's price.
$1,000 invested in NXL on Jul 31, 2025 (≈ 1,000 NXL) would be worth
$364.9
-$635.1 (-63.5%) today · 0.36× · US Dollar
Based on a NXL entry price of $1 vs. today's $0.3649.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.481 | $758.63 | -24.1% |
| 1 month ago | $0.38 | $960.26 | -4.0% |
| 3 months ago | $0.38 | $960.26 | -4.0% |
| 6 months ago | $0.573 | $636.82 | -36.3% |
| 1 year ago | $1 | $364.9 | -63.5% |
| All time (3.9y) ago | $2.25 | $162.18 | -83.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NXL forecast.
Our base-case forecast reaches $0.73 around 2034.
Implied market cap at $0.73: $16.07M
Across the multi-year forecast, Nexalin Technology, Inc. shows a path from a neutral near-term stance to meaningful longer-term upside. In 2030 the Avg price is $0.4169 with ROI 15.5% and sentiment Neutral.
The forecast then turns more bullish over the longer horizon, with 2040 Avg price $1.17 and ROI 223.5% and a bullish sentiment, and 2050 Avg price $1.36 with ROI 276.6% and a bullish sentiment. These figures imply substantial potential appreciation from current levels, but they are estimates and not guarantees. Investors should be aware of the inherent uncertainty and the possibility of downside risk.
Tap a question to reveal the answer.
The 2030 forecast shows an Avg price of $0.4169, a min of $0.2584, a max of $0.7223, with ROI 15.5% and sentiment Neutral.
Forecasts show a range of outcomes: 2026 Avg $0.3611 (ROI 0, Neutral) and 2027 Avg $0.4782 (ROI 32.4%, Bullish), with higher later-year ROIs and bullish sentiment in 2040 and 2050. These are estimates, not guarantees.
Yes. The forecasted max prices include $1.25 in 2033 and $1.57 in 2034, indicating the potential to exceed $1 in those years.
Current price is $0.3611 and market cap is $7.95M.
The near-term outlook is bearish with RSI 14 at 40. The 30-day range is $0.2237–$0.583, SMA50 at $0.4307, SMA200 at $0.6485, with support at $0.33 and resistance at $0.491.
Nexalin Technology, Inc. Community Discussion
0Share your Nexalin Technology, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.